152 related articles for article (PubMed ID: 17369680)
1. Long-term survival after radical resection for pancreatic head and ampullary cancer: a potential role for the EGF-R.
Smeenk HG; Erdmann J; van Dekken H; van Marion R; Hop WC; Jeekel J; van Eijck CH
Dig Surg; 2007; 24(1):38-45. PubMed ID: 17369680
[TBL] [Abstract][Full Text] [Related]
2. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Jang JY; Kim SW; Kang GH; Yoon YB
Ann Surg Oncol; 2007 Nov; 14(11):3195-201. PubMed ID: 17710498
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.
Ajiki T; Kamigaki T; Hasegawa Y; Fujino Y; Suzuki Y; Takeyama Y; Ku Y; Kuroda Y
Hepatogastroenterology; 2001; 48(41):1266-70. PubMed ID: 11677943
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer.
Uegaki K; Nio Y; Inoue Y; Minari Y; Sato Y; Song MM; Dong M; Tamura K
Anticancer Res; 1997; 17(5B):3841-7. PubMed ID: 9427790
[TBL] [Abstract][Full Text] [Related]
5. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
6. The morbidity, mortality, and prognostic factors for ampullary carcinoma and distal cholangiocarcinoma.
Shimizu Y; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Miyazaki M
Hepatogastroenterology; 2008; 55(82-83):699-703. PubMed ID: 18613437
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic head carcinoma: clinical analysis of 189 cases.
Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
[TBL] [Abstract][Full Text] [Related]
8. Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumor localization.
van Roest MH; Gouw AS; Peeters PM; Porte RJ; Slooff MJ; Fidler V; de Jong KP
Ann Surg; 2008 Jul; 248(1):97-103. PubMed ID: 18580212
[TBL] [Abstract][Full Text] [Related]
9. Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer.
Hsu HP; Yang TM; Hsieh YH; Shan YS; Lin PW
Ann Surg Oncol; 2007 Jan; 14(1):50-60. PubMed ID: 17054003
[TBL] [Abstract][Full Text] [Related]
10. Implications of histological grade of tumour for the prognosis of radically resected periampullary adenocarcinoma.
Sellner FJ; Riegler FM; Machacek E
Eur J Surg; 1999 Sep; 165(9):865-70. PubMed ID: 10533763
[TBL] [Abstract][Full Text] [Related]
11. HER-family gene amplification and expression in resected pancreatic cancer.
te Velde EA; Franke AC; van Hillegersberg R; Elshof SM; de Weger RW; Borel Rinkes IH; van Diest PJ
Eur J Surg Oncol; 2009 Oct; 35(10):1098-104. PubMed ID: 19304440
[TBL] [Abstract][Full Text] [Related]
12. The role of MIB-1 index in the prognosis of resectable pancreatic head cancer.
Shyr YM; Su CH; Li AF; Wu CW; Lui WY
Hepatogastroenterology; 1999; 46(29):2968-73. PubMed ID: 10576384
[TBL] [Abstract][Full Text] [Related]
13. Liver perfusion chemotherapy for selected patients at a high-risk of liver metastasis after resection of duodenal and ampullary cancers.
Noda T; Ohigashi H; Ishikawa O; Eguchi H; Yamada T; Sasaki Y; Yano M; Imaoka S
Ann Surg; 2007 Nov; 246(5):799-805. PubMed ID: 17968172
[TBL] [Abstract][Full Text] [Related]
14. Resection margin involvement and tumour origin in pancreatic head cancer.
Verbeke CS; Gladhaug IP
Br J Surg; 2012 Aug; 99(8):1036-49. PubMed ID: 22517199
[TBL] [Abstract][Full Text] [Related]
15. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor and its receptor as prognostic indicators in Chinese patients with pancreatic cancer.
Dong M; Nio Y; Guo KJ; Tamura K; Tian YL; Dong YT
Anticancer Res; 1998; 18(6B):4613-9. PubMed ID: 9891528
[TBL] [Abstract][Full Text] [Related]
17. Ampullary cancer and preoperative jaundice: possible indication of the minimal surgery.
Uchida H; Shibata K; Iwaki K; Kai S; Ohta M; Kitano S
Hepatogastroenterology; 2009; 56(93):1194-8. PubMed ID: 19760968
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
20. Stromal osteonectin overexpression is associated with poor outcome in patients with ampullary cancer.
Bloomston M; Ellison EC; Muscarella P; Al-Saif O; Martin EW; Melvin WS; Frankel WL
Ann Surg Oncol; 2007 Jan; 14(1):211-7. PubMed ID: 17080236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
